pomalidomide has been researched along with Anemia, Cooley's in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Engel, JD; Fucharoen, S; Hongeng, S; Jearawiriyapaisarn, N; Kaewsakulthong, W; Khamphikham, P; Nualkaew, T; Paiboonsukwong, K; Pongpaksupasin, P; Songdej, D; Sripichai, O | 1 |
| Brady, H; Chan, K; Corral, LG; Ferguson, GD; Glezer, E; Jensen-Pergakes, K; Morris, CL; Moutouh-de Parseval, LA; Muller, G; Verhelle, D | 1 |
2 other study(ies) available for pomalidomide and Anemia, Cooley's
| Article | Year |
|---|---|
High-level induction of fetal haemoglobin by pomalidomide in β-thalassaemia/HbE erythroid progenitor cells.
Topics: beta-Thalassemia; Erythroid Precursor Cells; Fetal Hemoglobin; Gene Expression Regulation; Hemoglobin E; Humans; Thalidomide | 2020 |
Pomalidomide and lenalidomide regulate erythropoiesis and fetal hemoglobin production in human CD34+ cells.
Topics: Anemia, Sickle Cell; Antigens, CD34; Antineoplastic Agents; Antisickling Agents; beta-Thalassemia; Blood Transfusion; Cells, Cultured; Clinical Trials as Topic; Drug Evaluation, Preclinical; Drug Synergism; Erythroid Cells; Erythropoiesis; Fetal Hemoglobin; Humans; Hydroxyurea; Lenalidomide; Models, Biological; Thalidomide; Up-Regulation | 2008 |